Rodolfo P. Rothlin
B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one.
Journal: Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology
Published: August 09, 2023
Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID-19.
Journal: Pharmacology research & perspectives
Published: November 26, 2022
Renin-Angiotensin System Inhibitors in Patients With COVID-19: A Meta-Analysis of Randomized Controlled Trials Led by the International Society of Hypertension.
Journal: Journal of the American Heart Association
Published: August 24, 2022
Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial.
Journal: EClinicalMedicine
Published: January 28, 2021
Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials.
Journal: Frontiers in pharmacology
Published: September 07, 2020
Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID-19.
Journal: Drug development research
Published: April 15, 2020
-759C>T Polymorphism of the HTR2C Gene is Associated with Second Generation Antipsychotic-Induced Weight Gain in Female Patients with Schizophrenia.
Journal: Pharmacopsychiatry
Published: July 15, 2016
Involvement of Extracellular Signal-Regulated Kinase 5 in Kinin B1 Receptor Upregulation in Isolated Human Umbilical Veins.
Journal: The Journal of pharmacology and experimental therapeutics
Published: October 21, 2015
Pharmacogenetics in psychiatry: how far are we from clinical application?
Journal: Vertex (Buenos Aires, Argentina)
Published: November 22, 2012
EV-077 in vitro inhibits platelet aggregation in type-2 diabetics on aspirin.
Journal: Thrombosis research
Published: May 18, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026